UPDATE – 28 NOVEMBER 2022
Further consultation
A second consultation on this standard opened on 28 November 2022. It closes on 7 December 2022.
Backgound to this consultation
The Ministry for Primary Industries (MPI) requested your feedback on the proposed changes to the MPI Treatment Provider Standard: Treatment Provider Requirements.
The standard sets out the requirements to all treatment providers requesting MPI approval to provide official treatments, IVAs authorised by MPI, and MPI inspectors under the Treatments Programme.
The draft document was the result of amalgamating the:
- Treatment Supplier Standard, and
- Treatment Programme: Overview and General Requirements for the Supply of Official Treatments
This was done for ease of access, to clarify roles and responsibilities of the programme participants, and improve references to government legislation and MPI standards.
Submissions closed on Friday, 5 August 2022.
Consultation document
Draft MPI Treatment Provider Standard: Treatment Provider Requirements [PDF, 986 KB]
Related documents
Treatment Supplier Standard [PDF, 678 KB]
Treatment Programme: Overview and General Requirements for the Supply of Official Treatments [PDF, 584 KB]
What was proposed?
The groups that were directly impacted and the corresponding key proposed changes are listed here.
MPI Approved Treatment Providers (previously called Treatment Suppliers)
All MPI Approved Treatment Providers (MATPs) contracted under the Treatment Provider Standard will be affected by the following key proposed changes:
- incorporated health and safety requirements to address health and safety concerns by updating the Contract of Approval with health and safety schedule and incorporating the requirements within the document. All MATPs are required to move to the new contract
- improved audit process
- added guidance statements to assist in the implementation of requirements.
MPI Approved post-border treatments at Post-Entry Quarantine (PEQ) facilities (imports only)
All PEQ operators who have applied to do on-arrival treatments at their own PEQ facilities will also be affected by the following key proposed changes:
- added documentation requirements
- formalised the current operational system
- added guidance statements to assist in the implementation of requirements.
MPI Approved Organisations (MAOs) with option 2 phytosanitary treatments (exports only)
All MAOs with option 2 phytosanitary treatments will also be affected by the consequences of the proposed changes, as follows:
- changes on the Standard will result to incorrect sections referred from the Treatment Provider Requirements as listed on Table 1 MAO Service Delivery Options and the Applicable of the MPI Certification: Organisation Standard
- only treatment providers that are contracted under the Treatment Supplier Programme are required to move to the updated version of the contract of approval. If an MAO is contracted only to the MPI Certification: Organisation Standard, the update on the contract of approval from the draft standard does not apply.
MPI Plant Exports and Plant Assurance teams have been consulted and are aware about the potential impact on the Plant Exports requirements. MPI will keep you posted regarding the alignment of the standards.
Full details of the proposed changes are in the consultation document.
Next steps
If there’s suitable justification, MPI will consider another round of consultation before the draft standard becomes final.
Submissions are public information
Note that all, part, or a summary of your submission may be published on this website. Most often this happens when we issue a document that reviews the submissions received.
Anyone can ask for copies of submissions under the Official Information Act 1982 (OIA). The OIA says we have to make submissions available unless we have a good reason for withholding it. That is explained in sections 6 and 9 of the OIA.
Let us know if you think there are grounds to withhold specific information in your submission. Reasons might include that it's commercially sensitive or it's personal information. However, any decision MPI makes to withhold information can be reviewed by the Ombudsman, who may require the information to be released.
